196 related articles for article (PubMed ID: 23827646)
1. Rosmarinus officinalis L. as cause of contact dermatitis.
Miroddi M; Calapai G; Isola S; Minciullo PL; Gangemi S
Allergol Immunopathol (Madr); 2014; 42(6):616-9. PubMed ID: 23827646
[TBL] [Abstract][Full Text] [Related]
2. Occupational allergic contact dermatitis from carnosol, a naturally-occurring compound present in rosemary.
Hjorther AB; Christophersen C; Hausen BM; Menné T
Contact Dermatitis; 1997 Sep; 37(3):99-100. PubMed ID: 9330813
[TBL] [Abstract][Full Text] [Related]
3. Concomitant allergic contact dermatitis due to Rosmarinus officinalis (rosemary) and Thymus vulgaris (thyme).
Martínez-González MC; Goday Buján JJ; Martínez Gómez W; Fonseca Capdevila E
Contact Dermatitis; 2007 Jan; 56(1):49-50. PubMed ID: 17177715
[No Abstract] [Full Text] [Related]
4. Rosemary contact dermatitis and cross-reactivity with other labiate plants.
González-Mahave I; Lobesa T; Del Pozo MD; Blasco A; Venturini M
Contact Dermatitis; 2006 Apr; 54(4):210-2. PubMed ID: 16650096
[TBL] [Abstract][Full Text] [Related]
5. Isolation, purification and characterisation of transglutaminase from rosemary (Rosmarinus officinalis L.) leaves.
El-Hofi M; Ismail A; Nour M; Ibrahim O
Acta Sci Pol Technol Aliment; 2014; 13(3):267-78. PubMed ID: 24887942
[TBL] [Abstract][Full Text] [Related]
6. Diterpenes from rosemary (Rosmarinus officinalis): Defining their potential for anti-cancer activity.
Petiwala SM; Johnson JJ
Cancer Lett; 2015 Oct; 367(2):93-102. PubMed ID: 26170168
[TBL] [Abstract][Full Text] [Related]
7. Rosemary (Rosmarinus officinalis L.) Extract as a Potential Complementary Agent in Anticancer Therapy.
González-Vallinas M; Reglero G; Ramírez de Molina A
Nutr Cancer; 2015; 67(8):1221-9. PubMed ID: 26452641
[TBL] [Abstract][Full Text] [Related]
8. Rapid quantitative enrichment of carnosic acid from rosemary (Rosmarinus officinalis L.) by isoelectric focused adsorptive bubble chromatography.
Backleh M; Leupold G; Parlar H
J Agric Food Chem; 2003 Feb; 51(5):1297-301. PubMed ID: 12590472
[TBL] [Abstract][Full Text] [Related]
9. Allergic contact dermatitis due to rosemary.
Serra E; Vila A; Peramiquel L; Dalmau J; Granel C; Alomar A
Contact Dermatitis; 2005 Sep; 53(3):179-80. PubMed ID: 16128769
[No Abstract] [Full Text] [Related]
10. Characterization of two genes for the biosynthesis of abietane-type diterpenes in rosemary (Rosmarinus officinalis) glandular trichomes.
Brückner K; Božić D; Manzano D; Papaefthimiou D; Pateraki I; Scheler U; Ferrer A; de Vos RC; Kanellis AK; Tissier A
Phytochemistry; 2014 May; 101():52-64. PubMed ID: 24569175
[TBL] [Abstract][Full Text] [Related]
11. Allergic contact dermatitis induced by rosemary leaf extract in a cleansing gel.
Inui S; Katayama I
J Dermatol; 2005 Aug; 32(8):667-9. PubMed ID: 16334869
[TBL] [Abstract][Full Text] [Related]
12. A Comprehensive Characterisation of Rosemary tea Obtained from Rosmarinus officinalis L. Collected in a sub-Humid Area of Tunisia.
Achour M; Mateos R; Ben Fredj M; Mtiraoui A; Bravo L; Saguem S
Phytochem Anal; 2018 Jan; 29(1):87-100. PubMed ID: 28895237
[TBL] [Abstract][Full Text] [Related]
13. Systemic administration of Rosmarinus officinalis attenuates the inflammatory response induced by carrageenan in the mouse model of pleurisy.
da Rosa JS; Facchin BM; Bastos J; Siqueira MA; Micke GA; Dalmarco EM; Pizzolatti MG; Fröde TS
Planta Med; 2013 Nov; 79(17):1605-14. PubMed ID: 24288274
[TBL] [Abstract][Full Text] [Related]
14. Degradation study of carnosic acid, carnosol, rosmarinic acid, and rosemary extract (Rosmarinus officinalis L.) assessed using HPLC.
Zhang Y; Smuts JP; Dodbiba E; Rangarajan R; Lang JC; Armstrong DW
J Agric Food Chem; 2012 Sep; 60(36):9305-14. PubMed ID: 22881034
[TBL] [Abstract][Full Text] [Related]
15. Investigation of rosemary herbal extracts (Rosmarinus officinalis) and their potential effects on immunity.
Ahmed HM; Babakir-Mina M
Phytother Res; 2020 Aug; 34(8):1829-1837. PubMed ID: 32086980
[TBL] [Abstract][Full Text] [Related]
16. Relationship between the antioxidant capacity and effect of rosemary (Rosmarinus officinalis L.) polyphenols on membrane phospholipid order.
Pérez-Fons L; Garzón MT; Micol V
J Agric Food Chem; 2010 Jan; 58(1):161-71. PubMed ID: 19924866
[TBL] [Abstract][Full Text] [Related]
17. Carnosic acid, a component of rosemary (Rosmarinus officinalis L.), promotes synthesis of nerve growth factor in T98G human glioblastoma cells.
Kosaka K; Yokoi T
Biol Pharm Bull; 2003 Nov; 26(11):1620-2. PubMed ID: 14600414
[TBL] [Abstract][Full Text] [Related]
18. Rosmarinus officinalis L. (rosemary) as therapeutic and prophylactic agent.
de Oliveira JR; Camargo SEA; de Oliveira LD
J Biomed Sci; 2019 Jan; 26(1):5. PubMed ID: 30621719
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid.
Huang MT; Ho CT; Wang ZY; Ferraro T; Lou YR; Stauber K; Ma W; Georgiadis C; Laskin JD; Conney AH
Cancer Res; 1994 Feb; 54(3):701-8. PubMed ID: 8306331
[TBL] [Abstract][Full Text] [Related]
20. Relevance of carnosic acid concentrations to the selection of rosemary, Rosmarinus officinalis (L.), accessions for optimization of antioxidant yield.
Wellwood CR; Cole RA
J Agric Food Chem; 2004 Oct; 52(20):6101-7. PubMed ID: 15453673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
